Position
Entropy Technologies, LP in Jazz Pharmaceuticals Plc
Back to the book · All holders of JAZZ
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $56K$170.00 → $189.05
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 28.5K | $4.84M | — | — | — | 0.3% |
| Q1 2026 | 2.94K | $556.2K | $189.05 | $56K | −$4.34M | 0.0% |